Mark Laret, chief executive officer of UCSF Medical Center and UCSF Benioff Children’s Hospital, says academic medical centers “must embrace profound, meaningful changes to time-honored, treasured and now increasingly ineffective and unaffordable ways of carrying out our missions.”
Latest News
May 31, 2013
UCSF’s Program for Breakthrough Biomedical Research “dares our scientists to dig deeper, ask tougher questions, and invent novel ideas and approaches that defy the status quo."
May 30, 2013
UCSF has long led the way in demonstrating the positive effects of living a healthy lifestyle. Turns out, a healthy lifestyle can not only keep illness at bay, but it may even stop a disease like cancer dead in its tracks.
May 29, 2013
The academic endeavors and innovative research that distinguish UC San Francisco were on display earlier this month at the 12th annual Inter-School Research and Scholarly Activity Festival.
May 20, 2013
A program that fosters basic science projects of potentially high impact that allow researchers to be creative, risky, and transformative is celebrating 15 years of discovery at UCSF.
May 16, 2013
UC San Francisco has launched a new app for the Apple iPad that presents a novel approach to learning the neurological physical exam, a challenging series of assessments aimed at diagnosing neurological disorders in patients.
May 14, 2013
Shinya Yamanaka's Nobel Prize for stem cell research brought fresh attention to something UCSF long ago sensed and seized: the promise of regeneration medicine for repairing or replacing damaged cells, tissues, and even whole organs.
May 13, 2013
UC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
May 09, 2013
Two UCSF scientists — brain researcher Michael Brainard, PhD, and cell biologist Dyche Mullins, PhD — have been selected to be Howard Hughes Medical Institute investigators.
May 08, 2013
UCSF recently convened experts to discuss cell therapies, which have already saved children and adults from leukemia in clinical trials after other drugs failed them.
